Larimar: Q2 Earnings Snapshot
The Bala Cynwyd, Pennsylvania-based company said it had a loss of 41 cents per share.
The results topped Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for a loss of 47 cents per share.
_____
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
The average rate on a 30-year mortgage fell to 6.54% this week, Freddie Mac says, the lowest since October
MCCLEAN, Va. (AP) — The average rate on a 30-year mortgage fell to 6.54% this week, Freddie Mac says, the lowest since October. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25 minutes ago
- Yahoo
Average rate on a 30-year mortgage drops to lowest level since October
MCLEAN, Va. (AP) — The average rate on a 30-year U.S. mortgage fell this week to its lowest level in nearly 10 months, giving prospective homebuyers a sorely needed boost in purchasing power that could help inject life into a stagnant housing market. The long-term rate fell to 6.58% from 6.63% last week, mortgage buyer Freddie Mac said Thursday. A year ago, the rate averaged 6.49%. Shop Top Mortgage Rates Personalized rates in minutes A quicker path to financial freedom Your Path to Homeownership Borrowing costs on 15-year fixed-rate mortgages, popular with homeowners refinancing their home loans, also fell. The average rate dropped to 5.71% from 5.75% last week. A year ago, it was 5.66%, Freddie Mac said. Elevated mortgage rates have helped keep the U.S. housing market in a sales slump since early 2022, when rates started to climb from the rock-bottom lows they reached during the pandemic. Home sales sank last year to their lowest level in nearly 30 years. This is the fourth week in a row that rates have come down. The latest average rate on a 30-year mortgage is now at its lowest level since Oct. 24, when it averaged 6.54%. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
an hour ago
- Yahoo
The Braff Group Advises IV Solutions, LLC in its Sale to Singlepoint Healthcare
PITTSBURGH, Aug. 14, 2025 /PRNewswire/ -- Singlepoint Healthcare, a portfolio of DFW Capital Partners announced last week the acquisition of IV Solutions, LLC (IVS), a leading provider of clinical pharmacy and home infusion services in Wood Dale, Ill. This acquisition helps establish a strong foundation for Singlepoint's integrated model and provide access to critical expertise in both clinical care and pharmaceutical services. The Braff Group served as the exclusive financial advisor for IV Solutions, LLC. Singlepoint is backed by DFW Capital Partners, a New York-based investor focused on partnering with growth-oriented healthcare and business services companies. The firm works alongside experienced management teams to accelerate expansion, enhance operations and build durable, scalable platforms that deliver long-term value. The company's initial platform includes The Boster Center for Multiple Sclerosis and IV Solutions. "IVS fit seamlessly into the Singlepoint Health multi-specialty network and allowed for the immediate growth of the Singlepoint model," commented Pat Clifford, The Braff Group Managing Director that headed up the deal team representing IV Solutions, LLC. About The Braff Group: Founded in 1998, The Braff Group is the leading health care advisory firm specializing exclusively in behavioral health, home health, home care and hospice, health care staffing, home medical equipment and pharmacy services. The firm has completed over 385 transactions and has been repeatedly ranked among the top five health care mergers and acquisitions advisory firms. Visit and follow The Braff Group on LinkedIn. Contact: Karen Cullen kcullen@ View original content to download multimedia: SOURCE The Braff Group Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
